The beginning of the Hanmi’s first generic development for a gout medicine ‘Feburic’

Published: 2014-10-14 13:32:24

Updated: 2014-10-14 13:36:37

Hanmi Pharmaceutical started on generic development of a gout medicine ‘Feburic (Febuxostat)’ as the very first domestic pharmaceutical company in Korea.

According to Ministry of Food and Drug Safety on the 10th, Hanmi Pharm has been approved to perform bioequivalence tests for Febuxostat.

Febuxostat is the main component of the gout medicine, ‘Feburic’. The product, developed by a Japanese p...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.